Psychotropic effects of antiepileptic drugs

被引:91
作者
Ettinger, Alan B. [1 ]
机构
[1] N Shore LIJ Comprehens Epilepsy Ctr, EEG Lab, New Hyde Pk, NY 11040 USA
关键词
D O I
10.1212/01.wnl.0000247045.85646.c0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Mood disorder symptoms are common in patients with epilepsy. Since antiepileptic drugs (AEDs) can affect these symptoms, knowledge of the psychotropic properties of AEDs is crucial. We review most studies of the psychotropic effects of AEDs that have involved potential psychiatric applications and have been reported in the psychiatric literature. Methods: We conducted a comprehensive literature search to identify relevant clinical trial reports on the efficacy of AEDs for mood disorders. Results: There have been few randomized controlled trials studying AED psychotropic properties in patients with epilepsy, but some randomized controlled trials of potential psychiatric indications for AEDs have been published. Data from these studies suggest that specific AEDs have mood stabilizing, anxiolytic, and antidepressant properties, while others may elicit depression, agitation, or psychosis. Conclusion: Antiepileptic drug selection should consider potential effects on mood and behavior.
引用
收藏
页码:1916 / 1925
页数:10
相关论文
共 124 条
[1]  
Altshuler L L, 1999, Bipolar Disord, V1, P61, DOI 10.1034/j.1399-5618.1999.10113.x
[2]   A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients [J].
Anand, A ;
Bukhari, L ;
Jennings, SA ;
Lee, C ;
Kamat, M ;
Shekhar, A ;
Nurnberger, JI ;
Lightfoot, J .
JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (02) :195-198
[3]   Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study [J].
Bahk, WM ;
Shin, YC ;
Woo, JM ;
Yoon, BH ;
Lee, JS ;
Jon, DI ;
Chung, SK ;
Choi, SK ;
Paik, IH ;
Pae, CU .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (01) :115-121
[4]   A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes [J].
Barbosa, L ;
Berk, M ;
Vorster, M .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (04) :403-407
[5]   Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode [J].
Benedetti, A ;
Lattanzi, L ;
Pini, S ;
Musetti, L ;
Dell'Osso, L ;
Cassano, GB .
JOURNAL OF AFFECTIVE DISORDERS, 2004, 79 (1-3) :273-277
[6]   Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder [J].
Berlant, Jeffrey L. .
BMC PSYCHIATRY, 2004, 4 (1)
[7]   Levetiracetam in bipolar spectrum disorders: first evidence of efficacy in an open, add- on study [J].
Bersani, G .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 (05) :355-356
[8]  
Besag Frank M C, 2004, Expert Opin Drug Saf, V3, P1
[9]   A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder [J].
Bowden, CL ;
Calabrese, JR ;
McElroy, SL ;
Gyulai, L ;
Wassef, A ;
Petty, F ;
Pope, HG ;
Chou, JCY ;
Keck, PE ;
Rhodes, LJ ;
Swann, AC ;
Hirschfeld, RMA ;
Wozniak, PJ .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (05) :481-489
[10]   A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder [J].
Bowden, CL ;
Calabrese, JR ;
Sachs, G ;
Yatham, LN ;
Asghar, SA ;
Hompland, M ;
Montgomery, P ;
Earl, N ;
Smoot, TM ;
DeVeaugh-Geiss, J .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (04) :392-400